Evidence map›Paper›PMID 23246282›Full record

ReviewSurvey of ophthalmology

Langerhans cell histiocytosis of the orbit: five clinicopathologic cases and review of the literature.

Martina C Herwig, Ted Wojno, Qing Zhang, Hans E Grossniklaus

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in Survey of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Steroid Induced Cataract in Langerhans Cell Histiocytosis Patient.Open access Macedonian journal of medical sciences · 2019
    Article
  19. Article
  20. Atypical presentation of isolated orbital Langerhans cell histiocytosis.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Martina C HerwigDepartment of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Ted Wojno
Qing Zhang
Hans E Grossniklaus
Emory University · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 1986 to 2025
$15.3M
NEI NIH HHS P30 EY006360NEI NIH HHS P30EY06360
6 · The paper itself

Abstract

Langerhans cell histiocytosis (LCH) is a proliferation of Langerhans cells intermixed with inflammatory cells, in particular eosinophils, that may manifest as unisystem (unifocal or multifocal) or multisystem disease. Orbital involvement typically manifests as a solitary lesion that carries a favorable prognosis. We describe the clinical and histologic spectrum of LCH of the orbit in our five cases. One patient exhibited multifocal unisystem disease; the other four had a localized process. Typical histologic features included numerous histiocytes with varying degrees of giant cell formation and scattered eosinophilic granulocytes. The presence of Langerhans cells was confirmed by CD1a and S100 immunohistochemistry. Transmission electron microscopy demonstrated characteristic intracytoplasmic Birbeck granules. We review the different ophthalmic manifestations of LCH and treatment strategies. As LCH may solely involve the orbit, treatment is based on the degree of organ involvement. LCH should included in the differential diagnosis in tumors of the ocular adnexae, especially in young children.

Indexed as

Cell ProliferationChildChild, PreschoolCurettageEosinophilsFemaleGiant CellsGlucocorticoidsHistiocytosis, Langerhans-CellHumansInfantInjections, IntralesionalLangerhans CellsMaleMethylprednisoloneOrbital DiseasesGlucocorticoidsMethylprednisolone

Identifiers

PMID23246282
PMCPMC4100607
OpenAlexW2068868974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.